1. REMICADE® becomes first anti-TNF biologic therapy to treat one million patients worldwide. Jonhson and Johnson [online] , (2007).
2. Five-year data demonstrate initial use of Abbott's HUMIRA® (adalimumab) plus methotrexate may prevent further joint damage in early rheumatoid arthritis patients. Abbott Laboratories [online] , (2009).
3. Thomson PDR. Red Book 2009: Pharmacy's Fundamental Reference. 111th edn (Thomson PDR, Montvale, 2009).
4. Barack Obama Comparative Effectiveness Health Plan Release. Barack Obama [online] , (2009).
5. Loftus, E. V. Jr, Schoenfeld, P. & Sandborn, W. J. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment. Pharmacol. Ther. 16, 51–60 (2002).